跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Glibemide
Approved
STANDARD
Glibemide
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
76606e92ad0d6e19
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
76606e92ad0d6e19
Drug Approval Philippines Name
Glibemide
Product Name
Glibemide
Registration Number
DRP-8367-01
Brand Name
Glibemide
Generic Name
Glibenclamide
Dosage Form
Tablet
Dosage Strength
5mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
777 Red Pharma Inc.
Issuance Date
29 April 2021
Expiry Date
24 February 2026
Pharmacologic Category
Sulfonylurea
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
76606e92ad0d6e19
Type
Standard
Back to Philippines FDA Approvals
Glibemide - Philippines FDA Drug Approval Details